 SOUTH SAN FRANCISCO, Calif., Nov. 30, 2020 PRNewswire -- Titan Pharmaceuticals, Inc. NASDAQ: TTNP Titan or the Company today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Companys common stock, which will be effective at 5:00 p.m... 